Intellia Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2015 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Intellia Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2015 to Q4 2023.
  • Intellia Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $616M, a 35.5% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $616M +$161M +35.5% Dec 31, 2023 10-K 2024-02-22
Q4 2022 $455M +$150M +49.2% Dec 31, 2022 10-K 2024-02-22
Q4 2021 $305M +$164M +116% Dec 31, 2021 10-K 2023-02-23
Q4 2020 $141M +$42.4M +43% Dec 31, 2020 10-K 2022-02-24
Q4 2019 $98.5M +$34.5M +53.8% Dec 31, 2019 10-K 2021-02-26
Q4 2018 $64M +$28.7M +81.1% Dec 31, 2018 10-K 2020-02-27
Q4 2017 $35.4M +$14.8M +72.1% Dec 31, 2017 10-K 2019-02-27
Q4 2016 $20.5M +$13.1M +176% Dec 31, 2016 10-K 2018-03-14
Q4 2015 $7.45M Dec 31, 2015 10-K 2017-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.